Skip to main content Back to Top
Advertisement

Act on Your Truth

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

In this final episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with former ASHP President Tom Johnson about the last step in the transformation process—acting on your truth. The ASHP leaders discuss how pharmacists need to embrace the many opportunities available to them in order to elevate their role throughout the healthcare system.

SPEAKERS

Tom JohnsonThomas J. Johnson is Assistant Vice President of Hospital Pharmacy at Avera Health, in Sioux Falls, S.D. He has consistently championed advancing optimal patient outcomes through the progressive use of pharmacy staff within healthcare teams.

Tom earned his Pharm.D. from North Dakota State University (NDSU) and completed an ASHP-accredited residency at St. Alexius Medical Center/NDSU in Bismarck, N.D. He has served in multiple roles over his professional career including clinical practice, academia, research, and leadership.

Tom has served ASHP in multiple roles including Treasurer (2016–2019); Board of Directors (2011–2014); Council on Education and Workforce Development; Council on Therapeutics; Committee on Nominations; Task Force on Organizational Structure; Practitioner Recognition Committee; and as a state delegate for many years. Tom is a Past President of the South Dakota Society of Health-System Pharmacists (SDSHP) and 2005 SDSHP Pharmacist of the Year. Currently Tom serves as ASHP President.

ASHP CEO Paul W. AbramowitzPaul W. Abramowitz is the Chief Executive Officer of the American Society of Health-System Pharmacists (ASHP).

Prior to joining ASHP in September 2011, Dr. Abramowitz worked in hospitals and health-systems for 34 years. He served as Associate Hospital Director for Professional Services and Chief Pharmacy Officer at the University of Iowa Hospitals and Clinics, and Professor at the University of Iowa College of Pharmacy. He also held prior positions as Director of Pharmacy and Associate Professor at the Medical College of Virginia and the University of Minnesota.

Abramowitz received a Bachelors Degree in Chemistry and Biology from Indiana University, a Bachelors Degree in Pharmacy from the University of Toledo, a Pharm.D. from the University of Michigan, and completed his residency at the University of Michigan Medical Center

In addition to serving as Treasurer of ASHP from 2007-10 and as ASHP President in 1993-94, he chaired the Boards of: the ASHP Research and Education Foundation, the Iowa Board of Pharmacy, and the Iowa Statewide Poison Control Center.

Dr. Abramowitz has actively combined practice, teaching, and research throughout his career. He has lectured and published extensively focusing on: the effect that pharmacists have on improving outcomes of care and reducing costs; developing new care models; reducing adverse drug events; and expanding comprehensive medication management to the ambulatory setting.

He was a recipient of the John W. Webb Lecture Award in 2000 and the Harvey A.K. Whitney Lecture Award in 2009, health-system pharmacy’s highest honor. In 1990, he received the Distinguished Alumni Award from the University of Toledo College of Pharmacy, in 2010, the Alumni Distinguished Lifetime Achievement Award from the University of Michigan College of Pharmacy, and in 2013 the Honorary Degree of Doctor of Science from the University of Toledo. In 2015, he was recognized as one of Washington’s Trending Association Leaders by Bisnow.

Currently, Dr. Abramowitz serves on the Boards of the American Nurses Foundation, the Pharmacy Technician Certification Board and the GTMRx Institute. He also is a member of the National Steering Committee for Patient Safety of the Institute for Healthcare Improvement and a Professor-Emeritus at the University of Iowa.





The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.